Matthew McManus

Insider Reports History

Location
Minneapolis, MN
Signature
/s/ Andrew Nick as Attorney-in-Fact for Matthew McManus pursuant to Power of Attorney previously filed.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew McManus:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Azenta, Inc. EVP & Chief Operating Officer COMMON 29.5K $1.67M $56.60 Aug 19, 2022 Direct
BIO-TECHNE Corp President - Diag & Spatial Bio Stock Option (Right to Buy) 24.6K $1.38M $56.22 Aug 15, 2025 Direct
Azenta, Inc. EVP & Chief Operating Officer Common Stock 20.8K $1.21M $57.96 Jan 24, 2022 Direct
BIO-TECHNE Corp President - Diag & Spatial Bio Performance Restricted Stock Units 19.2K $1.08M $56.22 Aug 15, 2025 Direct
BIO-TECHNE Corp President - Diag & Spatial Bio Restricted Stock Units 9.62K $541K $56.22 Aug 15, 2025 Direct
BIO-TECHNE Corp President - Diag & Spatial Bio Performance Stock Option (Right to Buy) 7.95K $447K $56.22 Aug 15, 2025 Direct
BIO-TECHNE Corp President - Diag & Spatial Bio Common Stock 4.74K $254K $53.60 Aug 15, 2025 Direct

Insider Reports Filed by Matthew McManus

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TECH BIO-TECHNE Corp Aug 15, 2025 6 -$47.2K 4 Aug 19, 2025 President - Diag & Spatial Bio
TECH BIO-TECHNE Corp Feb 1, 2025 3 -$121K 4 Feb 4, 2025 President - DGS
TECH BIO-TECHNE Corp Aug 15, 2024 1 $0 4/A Feb 3, 2025 President - DGS
TECH BIO-TECHNE Corp Feb 1, 2024 4 $0 4 Feb 5, 2024 President - DGS
TECH BIO-TECHNE Corp Jan 8, 2024 0 $0 3 Feb 5, 2024 President - DGS
AZTA Azenta, Inc. Aug 19, 2022 1 $502K 4 Aug 22, 2022 EVP & Chief Operating Officer
AZTA Azenta, Inc. Jan 24, 2022 0 $0 3 Feb 2, 2022 EVP & Chief Operating Officer